185 related articles for article (PubMed ID: 20953652)
1. Correlation between antimicrobial consumption and resistance among Staphylococcus aureus and enterococci causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2009.
Lai CC; Wang CY; Chu CC; Tan CK; Lu CL; Lee YL; Huang YT; Lee PI; Hsueh PR
Eur J Clin Microbiol Infect Dis; 2011 Feb; 30(2):265-71. PubMed ID: 20953652
[TBL] [Abstract][Full Text] [Related]
2. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci at a university hospital in Taiwan from 1991 to 2003: resistance trends, antibiotic usage and in vitro activities of newer antimicrobial agents.
Hsueh PR; Chen WH; Teng LJ; Luh KT
Int J Antimicrob Agents; 2005 Jul; 26(1):43-9. PubMed ID: 15975769
[TBL] [Abstract][Full Text] [Related]
3. Correlation between antimicrobial consumption and incidence of health-care-associated infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci at a university hospital in Taiwan from 2000 to 2010.
Lai CC; Chu CC; Cheng A; Huang YT; Hsueh PR
J Microbiol Immunol Infect; 2015 Aug; 48(4):431-6. PubMed ID: 24388582
[TBL] [Abstract][Full Text] [Related]
4. Correlation between Nosocomial Carriage of Vancomycin-Resistant Enterococci and Antimicrobial Use in Taiwan.
Lee MC; Lu CH; Lee WY; Lee CM
Am J Trop Med Hyg; 2020 Dec; 104(3):1131-1136. PubMed ID: 33319735
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial resistance rates in gram-positive bacteria do not drive glycopeptides use.
Gladstone BP; Cona A; Shamsrizi P; Vilken T; Kern WV; Malek N; Tacconelli E
PLoS One; 2017; 12(7):e0181358. PubMed ID: 28727741
[TBL] [Abstract][Full Text] [Related]
6. Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan.
Hsueh PR; Chen WH; Luh KT
Int J Antimicrob Agents; 2005 Dec; 26(6):463-72. PubMed ID: 16280243
[TBL] [Abstract][Full Text] [Related]
7. Decline in the incidence of healthcare-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) correlates with deceased antimicrobial consumption at a tertiary care hospital in Taiwan, 2001-2009.
Lee YT; Tsao SM; Lin HC; Huang HJ; Lee MC; Hsueh PR
Int J Antimicrob Agents; 2010 Dec; 36(6):523-30. PubMed ID: 20855186
[TBL] [Abstract][Full Text] [Related]
8. The dynamic relationship between antibiotic use and the incidence of vancomycin-resistant Enterococcus: time-series modelling of 7-year surveillance data in a tertiary-care hospital.
Kritsotakis EI; Christidou A; Roumbelaki M; Tselentis Y; Gikas A
Clin Microbiol Infect; 2008 Aug; 14(8):747-54. PubMed ID: 18727798
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study.
Wang Z; Cao B; Liu YM; Gu L; Wang C
Chin Med J (Engl); 2009 Jun; 122(11):1283-8. PubMed ID: 19567138
[TBL] [Abstract][Full Text] [Related]
10. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
Chen YH; Liu CY; Lu JJ; King CH; Hsueh PR
J Antimicrob Chemother; 2009 Dec; 64(6):1226-9. PubMed ID: 19833635
[TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections.
Drago L; De Vecchi E; Nicola L; Gismondo MR
BMC Infect Dis; 2007 Sep; 7():111. PubMed ID: 17888153
[TBL] [Abstract][Full Text] [Related]
13. An international multicenter study of antimicrobial consumption and resistance in Staphylococcus aureus isolates from 15 hospitals in 14 countries.
Westh H; Zinn CS; Rosdahl VT
Microb Drug Resist; 2004; 10(2):169-76. PubMed ID: 15256033
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic resistance in Staphylococcus aureus and its relevance in therapy.
Bal AM; Gould IM
Expert Opin Pharmacother; 2005 Oct; 6(13):2257-69. PubMed ID: 16218886
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.
Florescu I; Beuran M; Dimov R; Razbadauskas A; Bochan M; Fichev G; Dukart G; Babinchak T; Cooper CA; Ellis-Grosse EJ; Dartois N; Gandjini H;
J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i17-28. PubMed ID: 18684703
[TBL] [Abstract][Full Text] [Related]
16. Treatment of infective endocarditis caused by methicillin-resistant Staphylococcus aureus: teicoplanin versus vancomycin in a retrospective study.
Huang JH; Hsu RB
Scand J Infect Dis; 2008; 40(6-7):462-7. PubMed ID: 18584532
[TBL] [Abstract][Full Text] [Related]
17. Reduction in rates of methicillin-resistant Staphylococcus aureus infection after introduction of quarterly linezolid-vancomycin cycling in a surgical intensive care unit.
Smith RL; Evans HL; Chong TW; McElearney ST; Hedrick TL; Swenson BR; Scheld WM; Pruett TL; Sawyer RG
Surg Infect (Larchmt); 2008 Aug; 9(4):423-31. PubMed ID: 18759679
[TBL] [Abstract][Full Text] [Related]
18. Reduction of vancomycin-resistant enterococcal infections by limitation of broad-spectrum cephalosporin use in a trauma and burn intensive care unit.
May AK; Melton SM; McGwin G; Cross JM; Moser SA; Rue LW
Shock; 2000 Sep; 14(3):259-64. PubMed ID: 11028540
[TBL] [Abstract][Full Text] [Related]
19. Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
Smith JR; Yim J; Raut A; Rybak MJ
Antimicrob Agents Chemother; 2016 Apr; 60(4):2352-8. PubMed ID: 26833159
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
